Given the broad-ranging functions of E-cadherin on tissue organization, it is not surprising that alterations in its expression or structural modifications in its encoding gene CDH1 are common events during cancer progression and contribute to the aberrant morphogenetic effects in cancer [3,5,6]. This evidence concerns the gene CDH1 and cancer.